Topic Review
NK Cells—the Immune System against Glioblastoma
Glioblastoma (GBM) is the primary cancer with the highest incidence within the central nervous system. Natural killer (NK) cells are innate lymphocytes that play an important role in immunosurveillance, acting alongside other immune cells in the response against various types of malignant tumors and the prevention of metastasis. NK cells are being exploited in many ways to treat cancer. The broad arsenal of NK-based therapies includes adoptive transfer of in vitro expanded and activated cells, genetically engineered cells to contain chimeric antigen receptors (CAR-NKs), in vivo stimulation of NK cells (by cytokine therapy, checkpoint blockade therapies, etc.), and tumor-specific antibody-guided NK cells, among others. 
  • 561
  • 28 Feb 2022
Topic Review
Newborn and Child Health
Home-based records are paper or electronic records retained and used by mothers or caregivers to document the health services received for maternal, newborn, and child health. Little has been studied about the roles of these records on newborn and child health outcomes.
  • 731
  • 29 Jul 2021
Topic Review
New Treatments and Challenging Nutritional Interventions of SCD
Sickle cell disease (SCD), is a congenital blood disorder characterized by considerable phenotypic diversity. It comprises a group of disorders, with sickle cell anemia (SCA) being the most prevalent and serious genotype.
  • 146
  • 23 Jan 2024
Topic Review
New Model Regarding the Characteristics of Somatic Dysfunction
Somatic dysfunction (SD) is classified by the ICD 11 as a “Biomechanical lesion, not elsewhere classified”; however, the definitions are not equally shared and codified by osteopathic professionals.
  • 608
  • 14 Jun 2022
Topic Review
New COVID-19 Vaccinations
Vaccination can be, in fact, an efficient way to mitigate the devastating effect of the pandemic and offer protection to some vulnerable strata of the population (i.e., the elderly) and reduce the social and economic burden of the current crisis.
  • 643
  • 25 Mar 2021
Topic Review
Neuropsychological Outcomes Associated with COVID-19
Survivors of COVID-19 often report subjective, cognitive complaints following infection, grossly characterized by cognitive inefficiency or “brain fog”. The nature of their objective, neuropsychological presentations are only beginning to be characterized. Risk factors predictive of neuropsychological outcomes post-infection remain under study. The contagiousness and quick rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, as well as the significant impact of COVID-19 disease on public health, make the study of COVID-19 on neuropsychological functioning particularly important. 
  • 472
  • 05 May 2022
Topic Review
Neuropsychiatric Complications of SARS-CoV-2 Infection
Beginning with the various strategies of the SARS-CoV-2 virus to invade the bodies and manifest infection, and ending with the long COVID, people are witnessing the evolving course of the disease in addition to the pandemic. Given the partially controlled course of the COVID-19 pandemic, the greatest challenge lies in managing the short- and long-term complications of COVID-19.
  • 383
  • 20 Dec 2022
Topic Review
Neurogenic Inflammation
Migraine is a primary headache disorder characterized by a unilateral, throbbing, pulsing headache, which lasts for hours to days, and the pain can interfere with daily activities. It exhibits various symptoms, such as nausea, vomiting, sensitivity to light, sound, and odors, and physical activity consistently contributes to worsening pain. 
  • 1.6K
  • 28 Mar 2022
Topic Review
Neurogenic Bone Loss after Spinal Cord Injury
Osteoporosis is a common skeletal disorder which can severely limit one’s ability to complete daily tasks due to the increased risk of bone fractures, reducing quality of life. Spinal cord injury (SCI) can also result in osteoporosis and sarcopenia.
  • 106
  • 28 Sep 2023
Topic Review
Neurofibroma Development in Neurofibromatosis Type 1
Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome that affects about 1 in 3000 newborns, is caused by mutations in the NF1 gene and subsequent inactivation of its encoded neurofibromin. Neurofibromin is a tumor suppressor protein involved in the downregulation of Ras signaling. Despite a diverse clinical spectrum, one of several hallmarks of NF1 is a peripheral nerve sheath tumor (PNST), which comprises mixed nervous and fibrous components. The distinct spatiotemporal characteristics of plexiform and cutaneous neurofibromas have prompted hypotheses about the origin and developmental features of these tumors, involving various cellular transition processes. 
  • 371
  • 26 Sep 2022
  • Page
  • of
  • 182
Video Production Service